Radiographic Damage Repair Seen in One-Third of Patients With Psoriatic Arthritis

Key Clinical Summary

• A longitudinal cohort study published in Rheumatology found radiographic damage repair in 29.7% of patients with psoriatic arthritis (PsA) who developed structural joint damage during 7,189.5 person-years of follow-up.

• Combination therapy with methotrexate (MTX) plus biologic disease-modifying antirheumatic drugs (bDMARDs) was associated with a 52% reduction in radiographic progression (RR, 0.48; 95% CI, 0.38–0.62) and nearly twice the rate of radiographic repair (RR, 1.97; 95% CI, 1.13–3.45).

• The findings suggest that structural joint damage in PsA may not always be irreversible and that combination MTX-bDMARD therapy may favor both disease control and radiographic improvement.

Radiographic joint damage may be reversible in a subset of patients with psoriatic arthritis, according to a longitudinal cohort study published in Rheumatology. Investigators reported radiographic repair in nearly one-third of patients who developed structural joint damage and identified combination treatment with methotrexate (MTX) and biologic disease-modifying antirheumatic drugs (bDMARDs) as a predictor of both slower disease progression and structural improvement.

Study Findings

The study analyzed serial radiographs of the hands and feet from 674 patients with PsA, with imaging performed every two years. Structural damage was evaluated using the modified Steinbrocker score (mSS). Radiographic repair was defined as a decrease in the joint-level mSS, and multistate Markov models were used to estimate transitions between damage states and identify factors associated with repair.

The study population was 54.7% male, with a mean age of 44.4 years and a mean disease duration of 6.3 years at baseline. During 7,189.5 person-years of follow-up, 428 patients (63.4%) developed at least one damaged joint, defined as an mSS of 2 or greater.

Among those with structural damage, 127 patients (29.7%) experienced radiographic repair in at least one joint. Overall, investigators documented improvement in 361 individual joints, demonstrating that structural repair was measurable in a substantial proportion of affected patients.

Radiographic progression generally occurred before patients initiated biologic DMARD therapy. In contrast, individuals treated with MTX plus a biologic DMARD experienced significantly better structural outcomes. Combination therapy was associated with a 52% lower rate of radiographic progression (RR, 0.48; 95% CI, 0.38–0.62) and a 97% higher rate of radiographic repair (RR, 1.97; 95% CI, 1.13–3.45) compared with other treatment approaches.

Clinical Implications

Structural joint damage has traditionally been viewed as largely irreversible in inflammatory arthritis. These findings suggest that, in PsA, radiographic improvement may occur more frequently than previously recognized, particularly among patients receiving combination therapy with MTX and biologic DMARDs.

The results also reinforce the potential value of early and effective disease control before irreversible structural progression develops. Because radiographic progression was observed before biologic therapy initiation, timely escalation of treatment may help preserve joint integrity while increasing the likelihood of structural repair.

Although the observational design does not establish causality, the associations between combination therapy and both reduced progression and increased repair support further investigation into treatment strategies aimed not only at preventing joint damage but also at promoting structural recovery.

Expert Commentary

The study authors concluded that “radiographic improvement consistent with damage repair is not infrequent in PsA.” They further reported that “concomitant treatment with biologic DMARDs and MTX is a predictor of slower radiographic progression and damage repair.” These observations highlight the possibility that structural outcomes in PsA may be modified through combination therapy, although additional studies are needed to confirm these findings and clarify the underlying mechanisms.

The findings add to growing evidence that structural joint damage in psoriatic arthritis may be partially reversible in selected patients. Future research will be needed to determine which patients are most likely to experience radiographic repair and whether earlier initiation of combination therapy can further improve long-term structural outcomes.

Reference

Haddad A, Kharouf F, Lee KA, et al. Repair of radiographic joint damage in psoriatic arthritis: a cohort study. Rheumatology. 2026;65(6). doi:10.1093/rheumatology/keag258.